Wealth Architects, LLC Novo Nordisk A S Transaction History

Wealth Architects, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$69.3 - $90.95 $201,455 - $264,391	2,907 Added 145350.0%	2,909 $202,000
Q1 2025 May 12, 2025	SELL	$69.3 - $90.95 $202,356 - $265,574	-2,920 Reduced 99.93%	2 $0
Q4 2024 Feb 10, 2025	BUY	$85.0 - $120.04 $1,955 - $2,760	23 Added 0.79%	2,922 $251,000
Q2 2024 Aug 08, 2024	SELL	$122.71 - $146.91 $2,086 - $2,497	-17 Reduced 0.58%	2,899 $413,000
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $23,791 - $31,669	-233 Reduced 7.4%	2,916 $374,000

Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $4,125 - $4,956	47 Added 1.52%	3,149 $325,000
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $142,593 - $312,878	1,568 Added 102.22%	3,102 $282,000
Q2 2023 Aug 02, 2023	BUY	$155.98 - $172.65 $467 - $517	3 Added 0.2%	1,534 $248,000
Q1 2023 Apr 21, 2023	BUY	$132.34 - $159.14 $5,161 - $6,206	39 Added 2.61%	1,531 $243,000
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $153,004 - $201,912	1,492 New	1,492 $201,000

1,686

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Architects, LLC with notifications on news.